Stockreport

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Septerna, Inc.  (SEPN) 
PDF SEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers Ongoing Robust Financial Position of $561.6 Million Expected to Support Operations at Least into 20 [Read more]